EyeGate Receives Additional Milestone Payment from Valeant Pharmaceuticals for EGP-437
Sep 12, 2016 12:30 pm UTC| Business
WALTHAM, Mass., Sept. 12, 2016 -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing products for treating...
Sep 12, 2016 12:30 pm UTC| Business
NEW YORK and LONDON, Sept. 12, 2016 -- The regulatory challenges and cost pressures facing buy-side firms are putting further demands on the sell-side to prove their relationship value. According to conversations with...
Neuralstem Receives $20,000,000 Strategic Investment from Tianjin Pharmaceutical Group
Sep 12, 2016 12:03 pm UTC| Business
GERMANTOWN, Md., Sept. 12, 2016 -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, today announced that...
TESARO Receives FDA Fast Track Designation for Niraparib and Initiates Rolling NDA Submission
Sep 12, 2016 12:01 pm UTC| Business
WALTHAM, Mass., Sept. 12, 2016 -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to...
UniFirst Ranked No. 10 Best Company to Sell For
Sep 12, 2016 12:01 pm UTC| Business
WILMINGTON, Mass., Sept. 12, 2016 -- UniFirst Corporation (NYSE:UNF), an industry leader in the supply and servicing of uniforms, workwear, and ancillary facility products throughout the U.S. and Canada, has again...
RedHill Biopharma Announces Research Collaboration with Stanford University for YELIVA™
Sep 12, 2016 12:00 pm UTC| Business
TEL-AVIV, Israel, Sept. 12, 2016 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late...
Inovio’s Zika Vaccine Selected As 2016 Technology Breakthrough
Sep 12, 2016 12:00 pm UTC| Business
PLYMOUTH MEETING, Pa., Sept. 12, 2016 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that its Zika vaccine in development has been named a 2016 Technology Breakthrough by the editors of Popular Mechanics...